The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient-reported experience with an immunotherapy telehealth platform.
 
Robert Michael Daly
Stock and Other Ownership Interests - CVS Health (I); Lilly (I); Roche/Genentech
Consulting or Advisory Role - Varian Medical Systems
 
Erin Mary Bange
Consulting or Advisory Role - Flatiron Health
 
Sahil D Doshi
No Relationships to Disclose
 
Bob T. Li
Research Funding - Ambrx (Inst); Amgen (Inst); AstraZeneca (Inst); Bolt Biotherapeutics (Inst); Daiichi Sankyo (Inst); Hengrui Therapeutics (Inst); Lilly (Inst); MORE Health (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Karger Publishers - Book royalty; Shanghai Jiao Tong University Press - Book royalty; US62/514,661 (Inst); US62/685,057 (Inst)
Travel, Accommodations, Expenses - Amgen
(OPTIONAL) Uncompensated Relationships - Amgen; AstraZeneca; Boehringer Ingelheim; Daiichi Sankyo; Lilly
 
Neil J. Shah
Honoraria - MedNet, LLC; MedNet, LLC; MJH Life Sciences
Consulting or Advisory Role - Exelixis; Graticule; Merck Sharp & Dohme Corp.
Research Funding - Aravive (Inst); Exelixis
Travel, Accommodations, Expenses - Merck
 
David H Aggen
Consulting or Advisory Role - Alphasights; Aptitude Health; Astellas Pharma; Boehringer Ingelheim; Bristol Myers Squibb Foundation; Guidepoint Global Advisors; MJH Life Sciences; Seagen
Patents, Royalties, Other Intellectual Property - University of Illinois - Urbana Champaign
 
Ritesh R Kotecha
Consulting or Advisory Role - Eisai; Eisai; Guidepoint Inc; Guidepoint Inc
Research Funding - Allogene Therapeutics (Inst); Exelixis (Inst); Novartis (Inst); Pfizer (Inst); Takeda (Inst); Xencor (Inst)
 
Juliana Eng
No Relationships to Disclose
 
Kenneth K. Ng
No Relationships to Disclose
 
Fernanda C. G. Polubriaginof
No Relationships to Disclose
 
Gilad Kuperman
No Relationships to Disclose
 
Allison Lipitz-Snyderman
No Relationships to Disclose
 
Peter D. Stetson
No Relationships to Disclose
 
Deb Schrag
Stock and Other Ownership Interests - Merck (I)
Consulting or Advisory Role - JAMA-Journal of the American Medical Association; Swiss Re Management Ltd.
Research Funding - AACR (Inst); GRAIL (Inst)
Patents, Royalties, Other Intellectual Property - PRISSMM model is trademarked and curation tools are available to academic medical centers and government under creative commons license.
 
Katherine Panageas
Stock and Other Ownership Interests - 23andMe; Adicet Bio; Chinook Therapeutics; Codexis; T2 Biosystems; Vincerx Pharma
Research Funding - AACR (Inst)
Travel, Accommodations, Expenses - The Robert A. Winn Diversity in Clinical Trials Award Program (Winn Awards) in collaboration with the American Association for Cancer Research (AACR), Bristol Myers Squibb Foundation
 
Michael J. Morris
Stock and Other Ownership Interests - Doximity
Consulting or Advisory Role - Ambrx; Arvinas; AstraZeneca; Blue Earth Diagnostics; Bristol-Myers Squibb/Celgene; Clarity Pharmaceuticals; Convergent Therapeutics; Core Medica; Curium Pharma; Daiichi; Exelixis; Flare Therapeutics; Fusion Pharmaceuticals; ITM Isotope Technologies Munich; Lantheus Medical Imaging; Mashup Media; Pfizer; POINT Biopharma; Progenics; Telix Pharmaceuticals; Transtherabio; Z-Alpha
Research Funding - Astellas Pharma (Inst); Celgene (Inst); Corcept Therapeutics (Inst); Janssen (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Amgen; APCCC; AstraZeneca; Memorial Sloan-Kettering Cancer Center
Other Relationship - Novartis
(OPTIONAL) Uncompensated Relationships - Amgen; Amgen; Bayer; Janssen Oncology; Novartis